Related Experiment Video
Updated: Jul 11, 2026
09:04
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Methotrexate treatment for retained placental tissue
F Flam1, P O Karlström, B Carlsson
1Department of Obstetrics and Gynaecology, Karolinska Hospital, Stockholm, Sweden.
Summary
Methotrexate effectively treated placental polyps in three cases resistant to standard therapies. This suggests methotrexate has effects beyond just inhibiting trophoblastic cell division, offering a new treatment avenue.
Area of Science:
- Reproductive Medicine
- Gynecology
- Pharmacology
Background:
- Placental polyps are a rare gynecological condition.
- Conventional treatments include medical and surgical interventions.
- Treatment resistance necessitates exploring alternative therapeutic strategies.
Observation:
- Three patients presented with placental polyps unresponsive to standard treatments.
- Serum human chorionic gonadotropin (hCG) levels were negative in all cases.
- A single injection of methotrexate was administered to each patient.
Findings:
- Methotrexate successfully resolved placental polyps in all three patients.
- Treatment efficacy was observed despite negative serum hCG.
- This suggests methotrexate's mechanism of action may extend beyond anti-proliferative effects on trophoblastic cells.
Implications:
- Methotrexate represents a potential alternative treatment for refractory placental polyps.
- Further research is warranted to elucidate the full mechanism of methotrexate in this context.
- This finding could impact clinical management protocols for persistent placental polyps.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...